Havish Thatavarthi: New Advances in MIBC and Real-World Patient Care
Havish Thatavarthi and Diksha Sanjana Pasnoor

Havish Thatavarthi: New Advances in MIBC and Real-World Patient Care

Havish Thatavarthi, Founder at MathMinds, shared Diksha Sanjana Pasnoor’s, Co-Director of Clinical AI Research at MedNews Week, post on LinkedIn, adding:

“Great discussion with Dr. Karine Tawagi presented by MedNews Week and OncoDaily on how rapidly evolving advances in MIBC are translating into real-world patient care.

From emerging treatment strategies to ctDNA and surveillance, this comic does a great job of bringing the Spotlight together and walking through the key developments discussed throughout the conversation.

I really enjoyed listening to this discussion and hearing how new research and treatment advances are beginning to shape real-world decision-making in MIBC.

Watch the full Spotlight here.”

Quoting Diksha Sanjana Pasnoor’s post:

MedNews Week comics are back!

We illustrate our journey into the rapidly evolving world of muscle-invasive bladder cancer (MIBC) — with Dr. Karine Tawagi as our guide on the latest MedNewsWeek Spotlight.

From NIAGARA and perioperative chemo-immunotherapy to enfortumab vedotin + pembrolizumab, ctDNA, and surveillance, the treatment landscape in MIBC is changing fast.

But, with every new study comes an important question: How do we actually incorporate these advances into the way we treat our patients?

That is exactly the question we chase in this episode. Swipe to see our favourite moments of this conversation brought to life, one panel at a time. Catch this can’t-miss MNW episode on OncoDaily.

A huge thank you to Dr. Karine Tawagi for sharing her expertise and perspective with us!”

Havish Thatavarthi: New Advances in MIBC and Real-World Patient Care

Other articles about bladder cancer on OncoDaily.